Obese Non Diabetic(肥胖非糖尿病)研究综述
Obese Non Diabetic 肥胖非糖尿病 - Expression levels were also increased in adipose tissue of obese non-diabetic individuals as compared to obese diabetic patients. [1] Hmg20a transcript levels were also increased in adipose tissue of obese non-diabetic individuals as compared to obese diabetic patients. [2] Conclusion: The occurrence of MetS in 30% of our obese non-diabetic children and young adolescents pointed out to the necessity to impose early detection and preventive measures on a national scale. [3] To assess the relationship between glycometabolic parameters and OSA in obese non-diabetic subjects. [4] Significant elevation of MMP-7, MMP-9, PDGF and TGF-β was detected in obese diabetic COVID-19 patients compared to the non-obese non-diabetic group: 1044. [5] 50], Class-I-Obese non-diabetic 0. [6] Therefore, we studied the effects of a High Protein diet versus a High Carbohydrate diet in obese non-diabetic, prediabetic and diabetic subjects for effects on weight loss, blood sugar, lipid levels, inflammation, and oxidative stress. [7] Patients This prospective study was performed on 61 obese non-diabetic patients who underwent LSG. [8] The aim of the study was to evaluate the infarct-limiting effect of various types of bariatric surgery in non-obese non-diabetic rats. [9] Eight male non-obese non-diabetic patients with NAFLD underwent 6 experiments each lasting 8 hours: 1. [10] METHODS AND RESULTS We profiled >450 lipid species in 65 overweight/obese non-diabetic individuals. [11] Obese non-diabetic patients receiving semaglutide, an injectable long-acting GLP-1 receptor agonist, in a large randomized placebo-controlled trial, lost and maintained ∼15% of their body weight for over a year (Wilding et al. [12] 001) and obese diabetics had higher serum levels of OPG in comparison to obese non-diabetic patients (p < 0. [13] Gingival status was poor among obese and non-obese diabetic subjects (Groups 1 and 2) when compared with obese non-diabetic patients (Group 3). [14] Our results explored that OPG serum levels were higher in the control group compared to obese women and obese diabetics had higher serum levels of OPG in comparison to obese non-diabetic patients. [15] In obese non-diabetic youth, glucose response curve (GRC) and 1-hr glucose concentration during an oral glucose tolerance test (OGTT) represent novel biomarkers for T2D risk. [16] Many epidemiological studies indicate a relationship between obesity and diabetes and to better understand this relationship, we found it necessary to study the links between serum levels of various variables including insulin, vitamin E, and some cations involved in a major metabolic process incriminated in the pathophysiology of these two diseases: oxidative stress (we study magnesium (Mg), zinc (Zn) and calcium (Ca)), in obese diabetic type 2 and obese non diabetics. [17]与肥胖糖尿病患者相比，肥胖非糖尿病个体的脂肪组织中的表达水平也有所增加。 [1] 与肥胖的糖尿病患者相比，肥胖非糖尿病个体的脂肪组织中的 Hmg20a 转录水平也有所增加。 [2] 结论：我们 30% 的肥胖非糖尿病儿童和青少年发生 MetS 表明有必要在全国范围内实施早期检测和预防措施。 [3] 评估肥胖非糖尿病受试者的糖代谢参数与 OSA 之间的关系。 [4] 与非肥胖非糖尿病组相比，肥胖糖尿病 COVID-19 患者的 MMP-7、MMP-9、PDGF 和 TGF-β 显着升高：1044。 [5] 50]，I 级肥胖非糖尿病 0。 [6] 因此，我们研究了高蛋白饮食与高碳水化合物饮食对肥胖非糖尿病、糖尿病前期和糖尿病受试者的影响，以了解其对体重减轻、血糖、血脂水平、炎症和氧化应激的影响。 [7] 患者 这项前瞻性研究对 61 名接受 LSG 的肥胖非糖尿病患者进行。 [8] 该研究的目的是评估各种类型的减肥手术对非肥胖非糖尿病大鼠的梗死限制作用。 [9] 8 名患有 NAFLD 的非肥胖非糖尿病男性患者进行了 6 次实验，每次实验持续 8 小时： 1. [10] 方法和结果 我们分析了 65 名超重/肥胖非糖尿病个体中超过 450 种脂质种类。 [11] 在一项大型随机安慰剂对照试验中，接受 semaglutide（一种可注射的长效 GLP-1 受体激动剂）的肥胖非糖尿病患者在一年多的时间里减重并保持了约 15% 的体重（Wilding 等人。 [12] 001）和肥胖糖尿病患者的血清 OPG 水平高于肥胖的非糖尿病患者（p < 0. [13] 与肥胖的非糖尿病患者（第 3 组）相比，肥胖和非肥胖糖尿病患者（第 1 组和第 2 组）的牙龈状况较差。 [14] 我们的研究结果表明，与肥胖女性相比，对照组的 OPG 血清水平更高，与肥胖的非糖尿病患者相比，肥胖糖尿病患者的 OPG 血清水平更高。 [15] 在肥胖的非糖尿病青年中，口服葡萄糖耐量试验 (OGTT) 期间的葡萄糖反应曲线 (GRC) 和 1 小时葡萄糖浓度代表了 T2D 风险的新生物标志物。 [16] 许多流行病学研究表明肥胖与糖尿病之间存在关系，为了更好地理解这种关系，我们发现有必要研究各种变量的血清水平之间的联系，包括胰岛素、维生素 E 和参与病理生理学中涉及的主要代谢过程的一些阳离子这两种疾病中的一种：氧化应激（我们研究镁 (Mg)、锌 (Zn) 和钙 (Ca)）、肥胖的 2 型糖尿病患者和肥胖的非糖尿病患者。 [17]
body mass index 体重指数
Conclusion: This study shows that prolonged intermittent fasting such as Ramadan fasting can improve insulin sensitivity, improve lipid profile and reduce body weight and body mass index in obese non-diabetic patients undergoing Ramadan fasting. [1] Methods: One-hundred obese non-diabetic patients (body mass index, BMI: 42. [2] They were divided into three groups, 30 patients with type 2 diabetes mellitus with normal body mass index (BMI), 30 obese non-diabetic individuals and 30 obese type 2 diabetic patients. [3] Aims of the study were to compare fasting serum asprosin levels between obese children and controls and to investigate the relationships of asprosin with body mass index (BMI) and biochemical markers of insulin resistance, insulin sensitivity, β-cell function and cardio-metabolic risk in obese non-diabetic children. [4]结论：本研究表明，在斋月禁食的肥胖非糖尿病患者中，延长间歇性禁食（如斋月禁食）可以提高胰岛素敏感性、改善血脂、降低体重和体重指数。 [1] 方法：一百名肥胖的非糖尿病患者（体重指数，BMI：42. [2] 他们分为三组，30 名体重指数（BMI）正常的 2 型糖尿病患者，30 名肥胖非糖尿病患者和 30 名肥胖 2 型糖尿病患者。 [3] 本研究的目的是比较肥胖儿童和对照组的空腹血清白脂素水平，并探讨白脂素与体重指数 (BMI) 和胰岛素抵抗、胰岛素敏感性、β 细胞功能和心脏代谢风险等生化标志物的关系。肥胖的非糖尿病儿童。 [4]
group obese hyperglycemic 肥胖高血糖组
Obese non-diabetic (OND) group: obese rats without diabetes and no treatment conditions; SHAM group: obese-hyperglycemic rats treated with placebo; US group: obese-hyperglycemic rats treated with US; LASER group: obese-hyperglycemic rats treated with laser and; US+LASER group: obese-hyperglycemic rats treated with US plus laser. [1]肥胖非糖尿病（OND）组：无糖尿病且无治疗条件的肥胖大鼠； SHAM组：用安慰剂治疗的肥胖高血糖大鼠； US组：用US治疗的肥胖高血糖大鼠；激光组：用激光治疗的肥胖高血糖大鼠； US+LASER组：US+激光治疗的肥胖高血糖大鼠。 [1]